Introducing Jack Shumway, Ajinomoto CVC's first summer intern. Jack is a Stanford MBA candidate and is actively contributing to our investment strategy in gene and cell therapy, medical nutrition and more. Welcome to the team Jack! Maximilian Von Poelnitz Shunji Takehana Takamitsu Aisaka Hiroyuki Saito Yuki Tahara Yuichiro Ohno Yasuhiro Takenaka Winnie Leung
Ajinomoto Corporate Venture Capital
Venture Capital and Private Equity Principals
Palo Alto, California 713 followers
About us
Ajinomoto CVC is the corporate venture capital arm of Ajinomoto, a $10B revenue technology leader in amino science. We invest in transformative companies that advance new ways to extend health span, develop new approaches that change the ways information is processed, and answer complex challenges in sustainability. Together with Ajinomoto’s community of scientists and engineers, we enable startup founders to build and scale solutions for the future.
- Website
-
https://www.ajinomoto.com/
External link for Ajinomoto Corporate Venture Capital
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- Palo Alto, California
- Type
- Public Company
Locations
-
Primary
Get directions
350 Cambridge Ave
Palo Alto, California 94306, US
Employees at Ajinomoto Corporate Venture Capital
Updates
-
The Boston team at Ajinomoto Co., Inc. is looking for an experienced Business Development Director to drive new partnerships and M&As. If you know someone looking for growth opportunities in healthcare, biotechnology, and medical foods. Please share. https://shorturl.at/nsuMY Yasushi Noguchi, PhD Kenji Abe Shunji Takehana Jake Gonzales
-
-
MBA internship opportunity: Ajinomoto CVC is looking for a full-time summer MBA intern in the Palo Alto office. If you're passionate about deep tech and venture capital, learn more here: https://shorturl.at/DQUX8 Maximilian Von Poelnitz Shunji Takehana Yasuhiro Takenaka Hiroyuki Saito Winnie Leung Yuki Tahara Yuichiro Ohno
-
-
We welcomed a full house yesterday to launch the Ajinomoto CVC US office and to hear about skin-inspired electronics from Angela McIntyre of the Stanford Wearable Electronics Initiative (eWEAR). Thanks everyone for joining us and see you again soon. Shunji Takehana Maximilian Von Poelnitz Yasuhiro Takenaka Winnie Leung Hiroyuki Saito Yuichiro Ohno Yuki Tahara Translink Capital Ron Shigeta Rob Trice Atiye Bayman Tarun Verma Richard Curtin Brendan Walsh Celine Schiff-Deb
-
-
-
-
-
+1
-
-
Ajinomoto CVC portfolio company Elephantech Inc. closes $20M in its latest fundraising. Elephantech is the first company to mass-produce metal inkjet-printed circuit board, saving copper and water and enabling a cleaner PCB supply chain. Learn more here: https://lnkd.in/e5NWnb2S Hiroyuki Saito Yuichiro Ohno Maximilian Von Poelnitz Shunji Takehana Yasuhiro Takenaka Yuki Tahara Winnie Leung
Elephantech Inc. (CEO: Shinya Shimizu, Headquarters: Chuo-ku, Tokyo), a developer of innovative manufacturing technologies that significantly reduce water, resource, and energy consumption of printed circuit boards, has raised around 3 billion yen in its Series E financing. Elephantech conducted this financing round by utilizing JSDA Shares and Investment trusts for Professionals (J-Ships) with the support of Nomura Securities Co., Ltd. (President: Kentaro Okuda). With this latest round of funding, Elephantech's cumulative fundraising since its inception reaches approximately 15 billion yen (comprised of 9.5 billion yen through capital increases and 5.4 billion yen through loans and subsidies). https://lnkd.in/gXRYFbyj
-
-
The Ajinomoto CVC is hosting our inaugural open house happy hour + fireside chat on the future of skin-inspired electronics. Join us in Palo Alto on March 28. Guest speaker: Angela McIntyre, Executive Director of the Stanford Wearable Electronics (eWEAR) Initiative https://lu.ma/ube2fm1k Shunji Takehana Maximilian Von Poelnitz Winnie Leung Yoichiro Miwa
-
-
Announcement: Ajinomoto has set up a new US CVC team in Silicon Valley to expand startup investments in healthcare, semiconductors, batteries, and more. Portfolio companies will have access to Ajinomoto's expertise in advanced ingredient and material research as well as manufacturing capabilities from fermentation to biopharma CDMOs. https://lnkd.in/gK7dkyuh Hiroyuki Saito Shunji Takehana Maximilian Von Poelnitz Winnie Leung Yasuhiro Takenaka Yuki Tahara Yuichiro Ohno Yoichiro Miwa
-
Next week the Ajinomoto CVC team will be attending CES in Las Vegas and JP Morgan Healthcare Week in San Francisco. Send us a message to connect. Maximilian Von Poelnitz Shunji Takehana Winnie Leung Yoichiro Miwa #CES2024 #jpm2024
-
-
Just announced today: Ajinomoto has acquired Forge Biologics—a US-based gene therapy CDMO. Ajinomoto already has a portfolio of culture media and growth factors for gene and cell therapy. The newly added CDMO capabilities will allow us to further accelerate modalities targeting difficult hereditary diseases. In our CVC startup investments, we continue to look for disruptive companies with new modalities or that are advancing gene and cell therapies. Contact us if you’re one of them. Shunji Takehana Yasuhiro Takenaka Maximilian Von Poelnitz Hiroyuki Saito Yuichiro Ohno Winnie Leung Yoichiro Miwa Yuki Tahara https://lnkd.in/gwfc_zPX
Ajinomoto Acquires Forge Biologics, a US-Based Gene Therapy CDMO for JPY 82.8B
ajinomoto.com
-
New portfolio announcement: Ajinomoto CVC has just made our first investment in a semiconductor startup. Elephantech Inc. is the first company to mass produce printed circuit boards (PCBs) using metal inkjet printing. It eliminates steps like etching from standard subtractive manufacturing and reduces water and metal waste. Learn more about Elaphantech here. https://lnkd.in/d8MJWnS6 Hiroyuki Saito Shunji Takehana Yasuhiro Takenaka Ajinomoto Co., Inc.
Features of the P-Flex® Flexible Circuits
info.elephantech.co.jp